| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
MUSCLE CELL BIOLOGY AND CELL MOTILITY
1Department of Anatomy and Physiology, University of Padova, 35131 Padua, Italy; and 2Laboratory of Neuromuscular Plasticity, Institut Fédératif de Recherche 118, University of Sciences and Technologies, 59655 Villeneuve d'Ascq cedex, France
Submitted 25 September 2002 ; accepted in final form 10 May 2003
In striated muscles myosin light chain (MLC)2 phosphorylation regulates calcium sensitivity and mediates sarcomere organization. Little is known about the changes in MLC2 phosphorylation in relation to skeletal muscle plasticity. We studied changes in MLC2 phosphorylation in rats receiving three treatment conditions causing slow-to-fast transitions: 1) atrophy induced by 14 days of hindlimb suspension (HS), 2) hypertrophy induced by 14 days of clenbuterol administration (CB), and 3) 14 days of combined treatment (CB-HS). Three variants of the slow (MLC2s) and two variants of the fast MLC2 (MLC2f) isoform were separated with two-dimensional electrophoresis and identified with monoclonal and polyclonal antibodies specific for MLC2; their relative proportions were densitometrically quantified. In control soleus muscle MLC2s predominated over MLC2f (91.4 ± 3.9% vs. 8.5 ± 3.9%) and was separated into two spots, the less acidic spot being 73.5 ± 4.3% of the total. All treatments caused a decrease of the less acidic unphosphorylated spot of MLC2s (CB: 64.1 ± 5.6%, HS: 62.4 ± 6.8%, CB-HS: 56.4 ± 4.4%), the appearance of a third more acidic variant of MLC2s (representing 3.9–5.9% of total MLC2s), an increase of MLC2f (CB: 30.9 ± 3.1%, HS: 23.9 ± 3.3%, CB-HS: 25.3 ± 3.9%), and the phosphorylation of a large fraction of MLC2f (CB: 30.4 ± 6.7%, HS: 28.7 ± 6.5%, CB-HS: 21.8 ± 2.1%). Treatment with alkaline phosphatase or with protein phosphatase 1 (PP1) removed the most acidic spots of both MLC2f and MLC2s. We conclude that in rat skeletal muscles an increase of MLC2 phosphorylation is associated with the slow-to-fast transition regardless of whether hypertrophy or atrophy develops.
muscle atrophy; muscle hypertrophy; clenbuterol; hindlimb suspension
This article has been cited by other articles:
|
|
 |
|
  J. A. K. Birkeland, F. Swift, N. Tovsrud, U. Enger, P. K. Lunde, E. Qvigstad, F. O. Levy, O. M. Sejersted, and I. Sjaastad Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2367 - H2376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Shields, S. Dudley-Javoroski, and A. E. Littmann Postfatigue potentiation of the paralyzed soleus muscle: evidence for adaptation with long-term electrical stimulation training J Appl Physiol, August 1, 2006; 101(2): 556 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Picquet, V. Bouet, L. Cochon, M. Lacour, and M. Falempin Changes in rat soleus muscle phenotype consecutive to a growth in hypergravity followed by normogravity Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R217 - R224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bozzo, L. Stevens, V. Bouet, V. Montel, F. Picquet, M. Falempin, M. Lacour, and Y. Mounier Hypergravity from conception to adult stage: effects on contractile properties and skeletal muscle phenotype J. Exp. Biol., July 15, 2004; 207(16): 2793 - 2802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cieniewski-Bernard, B. Bastide, T. Lefebvre, J. Lemoine, Y. Mounier, and J.-C. Michalski Identification of O-linked N-Acetylglucosamine Proteins in Rat Skeletal Muscle Using Two-dimensional Gel Electrophoresis and Mass Spectrometry Mol. Cell. Proteomics, June 1, 2004; 3(6): 577 - 585. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
